Managing epilepsy with women in mind

Managing Epilepsy with Women in Mind

Volumn , Issue , 2005, Pages 1-157

  Betts, Tim ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846839894     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (66)

1. Betts T, Yarrow H, Dutton N, Grccnhill L, Rolfc T. A study of anticonvulsant medication on ovarian function in a group of women with epilepsy. Seizure 2003; 12: 323-9.
2. Campbell T, Betts T, Blake A, Grcenhill L. Beneficial effects of levetiracetam on photo and pattern sensitivity. American Epilepsy Society meeting. New Orleans, December 2004 [power].
3. Commission on Classification and Terminology of the International League Against Epilepsy. A proposal for revised seizure classification. Epilepsia 1981; 22: 489-501.
4. Engel J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE 2001 task force on classification and terminology. Epilepsia 2001; 42: 796-801.
5. Epilepsy - Death in the Shadows. National Sentinel Clinical Audit of Epilepsy - Related Death. Report (London, HMSO, 2002).
6. Fox C, Betts T. How much risk does a woman with active epilepsy pose to her newborn child in the puerperium? Seizure 1999; 8: 367-9.
7. Lockard J. A primare model of clinical epilepsy: mechanisms of acrion through quantification of rherapeuric effects. In: Lockard J, Ward A (eds). Epilepsy: a window to brain mechanisms. (New York, Raven I'ress, 1980), 11-9.
8. Milton J, Jung R Epilepsy as a dynamic disease. (Berlin, Springer, 2003).
9. Campbell T, Bens T, Blake A., Gteenhill L. Beneficial effects oflevetiracetam on photo and pattern sensitivity. American Epilepsy Society Meeting. New Orleans. December 2004 (poster).
10. Tuberous sclerosis … More Than Just Skin Deep, 1994. Leaflet obtainable from the Tuberous Sclerosis Association. Little Bamsley Farm, Otshill, Bromsgrove. Worcestershire. B6l ONQ, UK.
11. Betts T, Yarrow H., Dutton N., Greenhill L., Rolfc T. A study of anticonvulsant medication on ovarian function in a group of women with epilepsy. Seizure 2003; 12: 323-9.
12. Jehu D. Post traumatic stress reactions among adults molested as children. Sex and Marital Therapy 1991; 63: 227-43.
13. Sander J.W., Hart VM., Johnson AL. Shorvon SD. National general practice study of epilepsy: newly diagnosed epileptic seizures in a general population. Lancet 1990; 336: 1267-70.
14. Wyler A, Hermann B, Blumer D. Pscudo- pscudocpilcptic seizures. In: (Rowan A, Gates, J, eds) Non-Epileptic Seizures. (Boston, Butterworth- Heinemann. 1993) 73-84.
15. Blown S, Strong V. The use of seizure aien dogs. Seizure 2001; 10: 39-41.
16. Anseil B. Clarke E. Epilepsy and menstruation: the role of water retention. Lancet 1956; ii: 650-4.
17. Berts T, Crawford P. Women and epilepsy. (London, Martin Dunitz. 1998). 3-34.
18. Betts T. Yarrow H, Duiion N, Greenhill L. Rolfc T. A study of anticonvulsant medication on ovarian function in a group of women with epilepsy. Seizure 2003; 12: 323-9.
19. Crawford R Catamenial epilepsy. In: (Trimble M. ed). Women and epilepsy. (Chichester, John Wile 1. 1991). 159-65
20. Daraiaeri J., Richcns A. Effects of norethistcrone on seizures associated with menstruation. Epilepsia 1983;24: 377-81.
21. Duncan S, Read CL, Brodic MJ. How common is catamcnial epilepsy. Epilepsia 1993; 34: 827-31
22. Hcrzog A. Progesterone therapy in women with complex partial and secondarily generalized seizures. Neurology 1995; 45: 1660-2.
23. Hcrzog A. Disorders of reproduction and fertility. In: (Eogel J, Pedlcy T, cds). Epilepsy: a comprehensive rextbook. (Philadephia, Uppincott- Ravcn. 1997). 2013-19.
24. Heely M. Calvert R. Gibson J. Clobazam in catamcnial epilepsy. A model for evaluating anticonvulsants. Lancet 1982; ii: 71-3.
25. Krauss G, Brandt J. Campbell M. Plate C Summcrficld M. Anticpilcptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians. Neurology 1996; 46: 1534-7.
26. Lefevre F, Betes T. Do women who have hormonal evidence of die polycystic epilepsy syndrome whilst taking sodium valproate lose it if they switch to another anticonvulsant. American Epilepsy Society Meeting, New Orleans, December 2004 [poster].
27. Kumar N, Behari M, Ahiya GK, Jaikhani BL. Phenytoin levels in catamenial epilepsy. Epilepsia 1988; 29: 155-8.
28. Matlson R. Seizure frequency in the menstrual cycle. Epilepsia 1981; 22: 242-7.
29. Betes T, Fox C. Proactive pre-conception counselling for women with epilepsy - is it effective? Seizure 1999; 8: 322-7.
30. Adab N, Jacoby A, Smith D, Chadwick D. Additional educational needs for children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2001; 70: 15-21.
31. Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004; 75: 1575-83.
32. Betts T, Fox C. Proactive pre-conception counselling for women with epilepsy - is it effective? Seizure 1999; 8: 322-7.
33. Betts T, Yarrow H, Dutton N, Greenhill L, Rolfe T. A study of anticonvulsant medicine on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy. Seizure 2003:12; 323-9.
34. Betts T, Greenhill L, O'Donnell M, et al. A service for pregnant women with epilepsy - 2 years experience. American Epilepsy Society Meeting, New Orleans, December 2004 [poster].
35. Gaily E, Granstrom ML, Hiilesmaa V, Bardy A. Minor anomalies in offspring of epileptic mothers. JPaediatr 1988; 112:520-9.
36. Gaily E. Minor anomalies and effects on psychomotor development associated with maternal use of antiepileptic drugs. In: (Tomson T, Gram L, Sillanpaa M, Johnannessen S, eds). Epilepsy and pregnancy. (Chichester, Wrightson Biomedical, 1997), 63-70.
37. Johannessen S. Pharmacokinetics of antiepileptic drugs in pregnant women. In: (Tomson T, Gram L, Sillanpaa M, Johnannessen S. eds). Epilepsy and pregnancy. (Chichester, Wrightson Biomedical, 1997), 71-80.
38. Lander C, Eadie MJ. Plasma antiepileptic drug concentration during pregnancy. Epilepsia 1991; 32: 257-66.
39. Long L. Levetiracetam monotherapy during pregnancy: a case series. Epilepsy Behav 2003; 4: 447-8.
40. Meischenguisier R, D'Giano CH, Ferraro SM. Oxcarbazepine in pregnancy: clinical experience in Argentina. Epilepsy Behav 2004; 5:163-7.
41. Montouris G. Gabapentin exposure in human pregnancy: results from the gabapentin pregnancy register. Epilepsy Behav 2003; 4: 310-17.
42. Morrow J, Craig J. Anti-epileptic drugs in pregnancy: current safety and other issues. Expert Opin Pharmacother 2003; 4:445-56.
43. Nakane Y, Okuma T, Takahashi R et al. Multi- institutional study on the teratogencity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia 1980; 21:663-80.
44. Pelkonen O, Jouppila P, Karki NT. Attempts to induce drug metabolism in human fetal liver and placenta by the administration of phenobarbital to mothers. Arch Int Pharmacodyn Ther 1973; 202: 288-97.
45. Rane A. Fetal and neonatal disposition of drugs. In: (Tomson T, Gram L, Sillanpaa M, Johnannessen S, eds). Epilepsy and pregnancy. (Chichester, Wrightson Biomedical, 1997), 81-92.
46. Russell AJ, Craig JJ, Morrison P, et al. UK epilepsy and pregnancy group. Epilepsia 2004; 45: 1467.
47. Sander J, Hart YM, Johnson AL, Shorvon SD. National General Practice of Study of Epilepsy: newly diagnosed epileptic seizures in the general population. Lancet 1990; 336: 1267-70.
48. Sato M, Shirota M. Nagao T. Pantothenic acid decreases valproic acid induced neural tube defects in mice. Teratology 1995; 52: 143-8.
49. Steegers-Thenuissen R, Renier WO, Borm GF, et al. Factors influencing the risk of abnormal pregnancy outcome in epileptic women: a multicentre prospective study. Epilepsy Res 1994; 18: 261-9
50. Wilton L, Shakir S. A post-marketing surveillance study of gabapentin as add-on therapy for 3100 patients in England. Epilepsia 2002; 43: 983-92.
51. Yerby M, Koepsell T, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia, 1985; 26: 631-5.
52. Yerby M, Fricl PN, McCormick K. Antiepileptic drug disposition during pregnancy. Neurology 1992; 42(suppl 5): 12-16.
53. Berts T, Greenhill L, O'Donnell M, Whittle M, Pirie A. A service for pregnant women with epilepsy - 2 years experience- American Epilepsy Society Meeting, New Orleans, December 2004 [poster].
54. Yerby M, Koepsell T, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia 1985; 26: 631-5.
55. Betts X Crawfbrd P. Women and Epilepsy. (London, Martin Dunitz, 1998).
56. Betts T, Greenhill L, O'Donncll M, Whittle M, Pirie A. A service for pregnant women with epilepsy - 2 years experience. American Epilepsy Society Meeting, New Orleans, December 2004 [poster]. Fox C, Betts T. How much risk does a woman with active epilepsy pose to her newborn child in the puerperium? A pilot study. Seizure 1999; 8: 367-9.
57. Greenhill L., Betts T, Yarrow H, Patsalos P. Breast milk levels of lcvctiraccram post delivery. American Epilepsy Society meeting. New Orleans, December 2004 [poster].
58. Jager-Roman E, Deichl A, Jacob S. Fetal growth, major malformations and minor anomalies in infants born to women receiving valproic acid. J Paediatr 1986; 108: 997-1004.
59. Martin P, Millac P. Pregnancy and epilepsy: management and outcome: A 10-year prospective study. Seizure 1993; 2: 227-8.
60. Tomson T, Ohman J, Vitols S. Lamotrigine in pregnancy and lactation: a case report. Epilepsia 1997; 38: 1039-41.
61. Vinge, E. Breast feeding and antiepileptic drugs. In: (Tomson X Gram L, Sillanpaa M, Johnannessen S, eds). Epilepsy and Pregnancy (Chichester, Wrightson Biomedical 1997), 93-103.
62. Yerby M, Koepsell X, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia 1985; 26: 631-5.
63. Abbassi F, Krumholz A. Menopause and epilepsy. In: (Morrell M, Flynn K, eds) Women with epilepsy. (Cambridge, Cambridge University Press, 2003), 131-4.
64. Committee on Safety of Medicines. Current problems in pharmacovigiliance, Vol 30. (London, HMSO, 2004), 34-7.
65. Harden C, Pilver MC, Kavdin L, Jacobs AR. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 1999; 40: 1402-7.
66. Marcus R. Bone health in women with epilepsy. In: (Morrell M, Flynn K, eds) Women with epilepsy. (Cambridge, Cambridge University Press, 2003), 164-70.